Key Highlights
- Vijay Parthasarathy, Ph.D., MBA, joins Sunbird Bio as chief product and strategy officer.
- Will lead the strategic launch of Sunbird Bio’s blood-based diagnostic platform for neurodegenerative diseases.
- Previously served as VP of Product Management at Exact Sciences and held leadership roles at Philips.
- Brings expertise in diagnostics commercialization across multiple disease areas.
- Holds 15 patents and has authored over 30 scientific publications.
Source: Business Wire
Notable Quotes
- “We are thrilled to continue growing our team with the addition of Dr. Parthasarathy, an accomplished industry leader with a history of bringing innovative scientific advancements to market. His track record of successfully developing and commercializing diagnostics in multiple disease areas will be a tremendous asset to our team, accelerating the impact that our technology could have on patients with neurological disorders.” — John McDonough, Executive Chairman & CEO at Sunbird Bio
- “Sunbird Bio is a rapidly expanding company pioneering a first-of-its-kind, much-needed diagnostic platform for neurodegenerative diseases – an innovation that inspired me to join the team. This technology has real potential to meaningfully improve the lives of patients suffering from devastating neurodegenerative diseases, and I am excited to help bring it to those who need it most.” — Vijay Parthasarathy, Ph.D., MBA, Chief Product and Strategy Officer at Sunbird Bio
Why This Matters
Sunbird Bio’s appointment of Dr. Parthasarathy comes at a crucial time as the company advances its proprietary blood-based diagnostic platform. With a growing demand for precision neurology solutions, Dr. Parthasarathy’s expertise in bringing diagnostic innovations to market will be instrumental in shaping the company’s impact on Alzheimer’s, Parkinson’s, ALS, and other neurological diseases. His leadership strengthens Sunbird Bio’s position as a frontrunner in the field, bridging critical gaps in early and accurate disease detection.
